Construction Testing Articles & Analysis: Older
2 news found
Immatics’ IMA203CD8 candidate showed functional superiority among 20 tested CD8 constructs including CD8α. IND submission for IMA203CD8 as part of the Phase 1b study expansion cohort is expected in the first half of 2022. ...
The concept of pre-manufactured construction has been around for quite some time, and its use in the pharmaceutical and biotech industry is becoming increasingly common. ...
